2BBBullish & Bearish
Elanco Animal Health Incorporated Common Stock (ELAN) trades on NYSE. It operates in the Health Care sector, Drug Manufacturers - Specialty & Generic industry. Its current 2BB score is 28 out of 100.
Elanco Animal Health Incorporated is an American pharmaceutical company which produces medicines and vaccinations for pets and livestock. Until 2019, the company was a subsidiary of Eli Lilly and Company, before being divested. It is the third-largest animal health company in the world.
Elanco Animal Health Incorporated Common Stock’s current 2BB score is 28 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 0 | Very Low |
| Momentum | 50 | Stable |
| Financial strength | 49 | Normal |
| Quality | 100 | Very Strong |
| Risk | 37 | Low |
| CEO | Jeffrey N. Simmons |
| Headquarters | Indianapolis, Indiana, United States |
| Founded | 1954 |
| Employees | 9.65K |
| 52-week range | $17.11 – $27.98 |
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|---|---|---|---|
| 2027-02-22 | — | 0.1888 | — | $1.21B |
| 2026-11-03 | — | 0.2095 | — | $1.23B |
| 2026-08-05 | — | 0.2747 | — | $1.34B |
| 2026-05-06 | 0.4 | 0.3528 | $1.37B | $1.31B |